Peptide-specific CD8 T regulatory cells use IFN-gamma to elaborate TGF-beta-based suppression

J Immunol. 2005 Jun 15;174(12):7625-32. doi: 10.4049/jimmunol.174.12.7625.

Abstract

We identified a murine peptide-specific CD8 T regulatory cell population able to suppress responding CD4 T cells. Immunization with OVA, poly(I:C), and anti-4-1BB generated a population of SIINFEKL-specific CD8 T regulatory cells that profoundly inhibited peptide-responding CD4 T cells from cellular division. The mechanism of suppression required IFN-gamma, but IFN-gamma alone was not sufficient to suppress the responding CD4 T cells. The data show that CD8 T regulatory cells were unable to suppress unless they engaged IFN-gamma. Furthermore, even in the absence of recall with peptide, the CD8 T regulatory cells suppressed CD4 responses as long as IFN-gamma was present. To examine the effector mechanism of suppression, we showed that neutralizing TGF-beta inhibited suppression because inclusion of anti-TGF-beta rescued the proliferative capacity of the responding cells. TGF-beta-based suppression was dependent completely upon the CD8 T regulatory cells being capable of binding IFN-gamma. This was the case, although peptide recall of primed IFN-gamma (-/-) or IFN-gammaR(-/-) CD8 T cells up-regulated pro-TGF-beta protein as measured by surface latency-associated peptide expression but yet were unable to suppress. Finally, we asked whether the CD8 T regulatory cells were exposed to active TGF-beta in vivo and showed that only wild-type CD8 T regulatory cells expressed the TGF-beta-dependent biomarker CD103, suggesting that latency-associated peptide expression is not always congruent with elaboration of active TGF-beta. These data define a novel mechanism whereby IFN-gamma directly stimulates CD8 T regulatory cells to elaborate TGF-beta-based suppression. Ultimately, this mechanism may permit regulation of pathogenic Th1 responses by CD8 T regulatory cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigens, CD / biosynthesis
  • CD4-Positive T-Lymphocytes / immunology
  • Cell Proliferation
  • Cells, Cultured
  • Egg Proteins / administration & dosage
  • Egg Proteins / immunology*
  • Epitopes, T-Lymphocyte / administration & dosage
  • Epitopes, T-Lymphocyte / immunology*
  • Integrin alpha Chains / biosynthesis
  • Interferon gamma Receptor
  • Interferon-gamma / metabolism
  • Interferon-gamma / physiology*
  • Ligands
  • Lymphocyte Activation / immunology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Mutant Strains
  • Mice, Transgenic
  • Ovalbumin / administration & dosage
  • Ovalbumin / immunology*
  • Peptide Fragments
  • Protein Binding / immunology
  • Receptors, Interferon / metabolism
  • Receptors, Interferon / physiology
  • T-Lymphocytes, Regulatory / immunology*
  • T-Lymphocytes, Regulatory / metabolism*
  • Transforming Growth Factor beta / physiology*

Substances

  • Antigens, CD
  • Egg Proteins
  • Epitopes, T-Lymphocyte
  • Integrin alpha Chains
  • Ligands
  • OVA-8
  • Peptide Fragments
  • Receptors, Interferon
  • Transforming Growth Factor beta
  • alpha E integrins
  • Interferon-gamma
  • Ovalbumin